Allogene Therapeutics (ALLO) Tax Rate (2018 - 2019)
Allogene Therapeutics (ALLO) reported Tax Rate of 0.21% for Q4 2019, down 17.0% on a YoY basis from 0.26% in Q4 2018, and down 55.68% sequentially from 0.48% in Q2 2019.
Allogene Therapeutics (ALLO) Tax Rate (2018 - 2019) Analysis & Trends
Allogene Therapeutics (ALLO) has 2 years of Tax Rate data on file, last reported at 0.21% in Q4 2019.
- For the quarter ending Q4 2019, Tax Rate fell 17.0% year-over-year to 0.21%; the trailing twelve-month figure through Sep 2020 stood at 0.05% (down 18.0% YoY), and the FY2024 full-year result was 0.17%, changed N/A from the prior year.
- Tax Rate fell to 0.21% in Q4 2019, from 0.48% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 0.48% in Q2 2019 to a low of 0.16% in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -0.34 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 5.61 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 12.29 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.68 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 12.51 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -13.70 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Allogene Therapeutics | 421.71 Mn | 421.71 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 0.21 |
| Dec 31, 2019 | 0.21 |
| Dec 31, 2019 | 0.21 |
| Jun 30, 2019 | 0.48 |
| Jun 30, 2019 | 0.48 |
| Jun 30, 2019 | 0.48 |
| Mar 31, 2019 | 0.16 |
| Mar 31, 2019 | 0.16 |
| Mar 31, 2019 | 0.16 |
| Dec 31, 2018 | 0.38 |
| Dec 31, 2018 | 0.38 |
| Dec 31, 2018 | 0.38 |